Literature DB >> 25262300

Quantitative trait analysis of polymorphisms in two bilirubin metabolism enzymes to physiologic bilirubin levels in Chinese newborns.

Youyou Zhou1, San-Nan Wang2, Hong Li3, Weifeng Zha4, Qianqian Peng1, Shilin Li1, Ying Chen3, Li Jin5.   

Abstract

OBJECTIVE: To explore the effects of variants in Uridine Diphosphate Glucuronosyl Transferase 1A1 (UGT1A1) and Heme Oxygenase-1 (HMOX1) on daily physiological bilirubin levels and bilirubin changes during the first week after birth in Chinese newborns. Both UGT1A1 and HMOX1 code rate-limiting enzymes in the bilirubin metabolism pathway. STUDY
DESIGN: We conducted a retrospective quantitative trait study to analyze 4154 daily bilirubin values, 3129 bilirubin changes, and 11 polymorphisms of 988 newborns during the natural course of physiological hyperbilirubinemia.
RESULTS: For UGT1A1, we found minor allele A of rs4148323 (G211A, UGT1A1*6) contributed to higher daily bilirubin levels on days 4-6 (with contributions to variations increasing from 4.8% to 12.3%), minor allele T of rs887829 (c-364t) contributed to lower daily bilirubin levels for days 6 and 7 (with contributions to variations increasing from 7.0% to 10.2%) (P < .03 for all). In addition, minor alleles of rs887829 and (TA)n repeat (UGT1A1*28), and haplotype T-long-G at rs887829-(TA)n-rs4148323 were associated with a decrease in bilirubin levels from day 5 to day 6 (P < .01 for all). No contribution from HMOX1 was found.
CONCLUSION: Bilirubin levels and changes during the middle and late parts of the first week were attributed to variants and haplotypes in UGT1A1. This quantitative trait study may provide a more robust statistical method for determining the association of genetic factors and bilirubin kinetics to predict the development of neonatal bilirubin in early postnatal life.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25262300     DOI: 10.1016/j.jpeds.2014.08.041

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

Review 1.  Uridine 5'-diphospho-glucronosyltrasferase: Its role in pharmacogenomics and human disease.

Authors:  Celia N Sanchez-Dominguez; Hugo L Gallardo-Blanco; Mauricio A Salinas-Santander; Rocio Ortiz-Lopez
Journal:  Exp Ther Med       Date:  2018-05-18       Impact factor: 2.447

Review 2.  Heme oxygenase-1 promoter polymorphisms: do they modulate neonatal hyperbilirubinemia?

Authors:  M Kaplan; R J Wong; D K Stevenson
Journal:  J Perinatol       Date:  2017-02-16       Impact factor: 2.521

3.  Multiple Genetic Modifiers of Bilirubin Metabolism Involvement in Significant Neonatal Hyperbilirubinemia in Patients of Chinese Descent.

Authors:  Hui Yang; Qian Wang; Lei Zheng; Min Lin; Xiang-bin Zheng; Fen Lin; Li-Ye Yang
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

4.  Risk assessment of gene variants for neonatal hyperbilirubinemia in Taiwan.

Authors:  Yi-Hao Weng; Ya-Wen Chiu; Shao-Wen Cheng; Chun-Yuh Yang
Journal:  BMC Pediatr       Date:  2016-08-24       Impact factor: 2.125

5.  Ensemble learning for the early prediction of neonatal jaundice with genetic features.

Authors:  Haowen Deng; Youyou Zhou; Lin Wang; Cheng Zhang
Journal:  BMC Med Inform Decis Mak       Date:  2021-12-01       Impact factor: 2.796

Review 6.  Association between HO‑1 gene promoter polymorphisms and diseases (Review).

Authors:  Lin-Lin Ma; Lei Sun; Yu-Xi Wang; Bai-He Sun; Yan-Fei Li; Yue-Ling Jin
Journal:  Mol Med Rep       Date:  2021-11-29       Impact factor: 2.952

Review 7.  The Role of Heme Oxygenase-1 Promoter Polymorphisms in Perinatal Disease.

Authors:  Ruka Nakasone; Mariko Ashina; Shinya Abe; Kenji Tanimura; Hans Van Rostenberghe; Kazumichi Fujioka
Journal:  Int J Environ Res Public Health       Date:  2021-03-29       Impact factor: 3.390

8.  UGT1A1 mutation association with increased bilirubin levels and severity of unconjugated hyperbilirubinemia in ABO incompatible newborns of China.

Authors:  Hui Yang; Fen Lin; Zi-Kai Chen; Lin Zhang; Jia-Xin Xu; Yong-Hao Wu; Jing-Ying Gu; Yu-Bin Ma; Jian-Dong Li; Li-Ye Yang
Journal:  BMC Pediatr       Date:  2021-06-01       Impact factor: 2.125

9.  A UGT1A1 variant is associated with serum total bilirubin levels, which are causal for hypertension in African-ancestry individuals.

Authors:  Guanjie Chen; Adebowale Adeyemo; Jie Zhou; Ayo P Doumatey; Amy R Bentley; Kenneth Ekoru; Daniel Shriner; Charles N Rotimi
Journal:  NPJ Genom Med       Date:  2021-06-11       Impact factor: 8.617

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.